The World Market for Diabetes Treatments.pdf
《The World Market for Diabetes Treatments.pdf》由会员分享,可在线阅读,更多相关《The World Market for Diabetes Treatments.pdf(270页珍藏版)》请在三一文库上搜索。
1、World Market for Diabetes Treatments Rures adquireret umbraculi, etiam tremulus matrimonii libere senesceret app October 2010 Kalorama Information A division of MarketR 38 East 29th Street Sixth Floor New York, New York 10016 212.807 .2660 t 800.298.5603 t 212.807 .2676 f Copyright 2010 Kalorama In
2、formation Reproduction without written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited WORLDWIDE MARKET FOR DIABETES THERAPEUTICS A KALORAMA INFORMATION MARKET INTELLIGENCE REPORT The Worldwide Market for Diabetes Therapeutics has bee
3、n prepared by Kalorama Information. We serve business and industrial clients in the United States and abroad with a complete line of information services and research publications. Kalorama Information Market Intelligence Reports are specifically designed to aid the action-oriented executive by prov
4、iding a thorough presentation of essential data and concise analysis. Author: Mary Anne Crandall Publication Date: 38 East 29th Street New York, New York 10016 (800) 298-5699 Outside the U.S. (212) 807-2657 FAX: (212) 807-2676 www.KaloramaI E-MAIL: Copyright 2010 Kalorama Information Reproduction w
5、ithout written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited Copyright 2010 Kalorama Information Reproduction without written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly pro
6、hibited Copyright 2010 Kalorama Information Reproduction without written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited TABLE OF CONTENTS CHAPTER ONE: EXECUTIVE SUMMARY7 Background7 Scope and Methodology7 Size and Growth of the Marke
7、t8 Key Issues and Trends Affecting Market10 Leading Competitors.11 CHAPTER TWO: INTRODUCTION.13 Background13 Therapeutic Practices15 France16 Germany17 Italy .19 Japan21 Spain22 United Kingdom24 United States .25 China.28 India 29 Current Therapeutics for Diabetes31 Insulin33 Regular Insulin .34 Lon
8、g-Acting and Basal Insulin.34 Rapidly Acting Insulin 34 Combinations34 Insulin Pumps .35 Insulin Pens.35 Inhaled Insulin35 Other Treatments36 Oral Hypoglycemics38 Sulfonylureas 38 Biguanides 39 -Glucosidase Inhibitors.40 Thiazolidinediones40 Meglitinides 41 D-Phenylalanine Derivatives42 GLP1 Agonist
9、s42 DPP-IV Inhibitor 43 Current Therapeutics for Diabetic Complications.45 Antihypertensive Therapy.45 Copyright 2010 Kalorama Information Reproduction without written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited ACE Inhibitors47 /
10、(Alpha/Beta)-Blockers.49 Calcium Channel Blockers.50 Diuretics.52 Angiotensin II Receptor Antagonists54 Dyslipidemia Therapy 56 HMG-CoA Reductase Inhibitors-Statins.58 Bile Acid Sequestrants58 Fibric Acid Derivatives58 Niacin.59 Cholesterol Absorption Inhibitors59 Atherosclerosis Therapy.61 Arrhythm
11、ia Therapy .61 Peripheral Vascular Disease Therapy.63 CHAPTER THREE: TOTAL MARKET REVENUES, FORECAST AND COMPETITIVE ANALYSIS69 Total Worldwide Diabetes Market Analysis by Geographic Segment.72 Total Worldwide Diabetes Market Competitive Analysis76 Total Worldwide Diabetes Market by Segment.77 Insul
12、in.77 Oral Hypoglycemics.87 CHAPTER FOUR: KEY ISSUES, TRENDS AND DEVELOPMENTS .99 New Products and the Development Pipeline.100 Afrezza105 Bydureon 106 Syncria106 AVE0010 Once Daily and Twice Daily106 Balaglitazone107 Dapagliflozin and Dapagliflozin/Meformin Fixed Dose Combination107 Degludec and De
13、gludec Plus.107 Daimyd Vaccine .107 Dutogliptin .107 Glinsuma, Glufast, Metgluna .108 MK 0431C108 Ondero108 Oral-lyn108 Otelixizumab.109 Taspoglutide.109 Transplantation Research Efforts.109 -Cell Transplantation Research.109 Potential New Drug for Type 2 Diabetes.125 Insulin Pills126 Copyright 2010
14、 Kalorama Information Reproduction without written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited Three-month Insulin Shot.126 Outsourcing of Diabetes Projects.127 Reclassification of Cause of Death.128 CHAPTER FIVE: NUTRITIONAL SUPP
15、LEMENT AND HERBAL APPROACHES TO THE TREATMENT OF DIABETES129 Background129 Nutritional Supplements.130 Ascorbic Acid (Vitamin C).130 Biotin.131 Chromium .132 Copper.134 Magnesium134 Niacin and Niacinamide135 Potassium137 Selenium137 Thiamine .138 Vanadium138 Vitamin B6 (Pyridoxine).139 Vitamin B1214
16、0 Vitamin E140 Zinc .141 Nutritional Treatment of Diabetic Neuropathy.142 Herbal Treatment of Diabetes143 Aloe (Various).144 Arctium lappa (Burdock Root)144 Allium cepa (Onion)144 Grifola frondosa (Maitake Mushroom).145 Mulberry145 Panax ginseng (Korean ginseng) 146 Ayurvedic Medicine and Herbs147 G
17、ymnema sylvestre (Asclepias germinata)147 Momordica charantia (Bitter Gourd)150 Trigonella foenum graecum (Fenugreek)152 Other Herbs with Significant Anti-Diabetic Effects.157 Traditional Chinese Medicine159 CHAPTER SIX: CONCLUSIONS AND STRATEGIC IMPLICATIONS.163 First Conclusion.163 Implications:16
18、3 Second Conclusion.166 Implications:166 Copyright 2010 Kalorama Information Reproduction without written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited Third Conclusion 167 Implications:.167 Fourth Conclusion 168 Implications:.168 F
19、ifth Conclusion169 Implications:.170 Sixth Conclusion170 Implications:.170 Seventh Conclusion.171 Implications:.171 Eighth Conclusion.173 Implications:.173 Ninth Conclusion.173 Implications:.174 Tenth Conclusion174 Implications:.175 Eleventh Conclusion .175 Implications:.175 Twelfth Conclusion.176 I
20、mplications:.176 Thirteenth Conclusion177 Implications:.177 Fourteenth Conclusion .178 Implications:.178 Fifteenth Conclusion.179 Implications:.179 CHAPTER SEVEN: LEADING MANUFACTURERS.181 Overview181 Amylin Pharmaceuticals.184 AstraZeneca.189 GlaxoSmithKline.192 Eli Lilly world demographics; life e
21、xpectancy by country, and other general issues affecting the market. Information is presented as a worldwide Executive Summary 8 Copyright 2010 Kalorama Information Reproduction without written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly pro
22、hibited overview, with special emphasis on the U.S., Europe, and other key markets. A market summary includes market analysis by product and region and a competitive analysis of leading providers. Additionally, key company profiles are included. The information for this report was gathered using bot
23、h primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this
24、 study, Kalorama Information conducted interviews with more than 25 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Add
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- The World Market for Diabetes Treatments
链接地址:https://www.31doc.com/p-3800884.html